Ciccarelli, Nicoletta
 Distribuzione geografica
Continente #
EU - Europa 3.710
NA - Nord America 2.991
AS - Asia 1.868
SA - Sud America 422
AF - Africa 81
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 9.122
Nazione #
US - Stati Uniti d'America 2.864
DE - Germania 1.041
SG - Singapore 847
IT - Italia 723
CN - Cina 450
SE - Svezia 411
FR - Francia 364
BR - Brasile 360
PL - Polonia 287
GB - Regno Unito 249
UA - Ucraina 139
IE - Irlanda 118
IN - India 104
VN - Vietnam 76
FI - Finlandia 72
ID - Indonesia 71
CA - Canada 69
ES - Italia 59
KR - Corea 55
HK - Hong Kong 45
RU - Federazione Russa 44
AU - Australia 39
MX - Messico 36
TR - Turchia 36
PT - Portogallo 35
BE - Belgio 32
AR - Argentina 31
JP - Giappone 29
NL - Olanda 27
BD - Bangladesh 25
ZA - Sudafrica 25
AT - Austria 24
IR - Iran 18
IQ - Iraq 17
CI - Costa d'Avorio 16
PH - Filippine 13
PK - Pakistan 13
GR - Grecia 12
RO - Romania 12
CZ - Repubblica Ceca 11
CH - Svizzera 9
NO - Norvegia 9
CM - Camerun 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
NZ - Nuova Zelanda 7
VE - Venezuela 7
CO - Colombia 6
JM - Giamaica 6
MA - Marocco 6
NG - Nigeria 6
TW - Taiwan 6
CL - Cile 5
DO - Repubblica Dominicana 5
EC - Ecuador 5
EG - Egitto 5
JO - Giordania 5
LT - Lituania 5
QA - Qatar 5
HR - Croazia 4
LB - Libano 4
TH - Thailandia 4
UG - Uganda 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
OM - Oman 2
PA - Panama 2
SM - San Marino 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
LU - Lussemburgo 1
Totale 9.113
Città #
Chandler 472
Singapore 376
Kraków 263
Ashburn 244
Milan 154
New York 141
Jacksonville 122
Dublin 115
San Mateo 102
Beijing 94
Ann Arbor 83
Los Angeles 78
Cattolica 77
Nanjing 65
Jakarta 62
Nürnberg 58
Dearborn 54
Redwood City 52
Boston 49
Wilmington 47
Houston 46
Dallas 39
Woodbridge 39
Rome 35
Hefei 34
Helsinki 34
Redmond 34
Hong Kong 31
London 31
Ho Chi Minh City 29
Chicago 28
Frankfurt am Main 28
Lawrence 28
Princeton 28
São Paulo 27
Brussels 26
Paris 25
Seattle 25
Ottawa 24
Izmir 23
Lancaster 23
Munich 23
Moscow 22
Tokyo 22
Buffalo 20
Augusta 19
Marseille 19
Nanchang 19
Santa Clara 19
The Dalles 19
Montreal 17
Hanoi 16
Mountain View 16
Rio de Janeiro 16
Warsaw 16
Fairfield 15
Manchester 15
Orem 15
Shenyang 15
Toronto 15
Vienna 15
Abidjan 14
Bremen 14
Catania 14
Norwalk 14
Amsterdam 13
Johannesburg 13
Leawood 13
Madrid 13
Poplar 13
Turin 13
Changsha 12
Hyderabad 12
Seoul 12
Atlanta 11
Denver 11
Boardman 10
Brasília 10
Brescia 10
Cantù 10
Florence 10
Glasgow 10
Guangzhou 10
Kunming 10
Lauterbourg 10
Brooklyn 9
Chennai 9
Andover 8
Cambridge 8
Capua 8
Hebei 8
Jiaxing 8
Lisbon 8
Melbourne 8
Oslo 8
Phoenix 8
Porto 8
San Francisco 8
Stockholm 8
Trieste 8
Totale 4.102
Nome #
The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study 463
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 353
OXFORD COGNITIVE SCREEN (OCS) FEASIBILITY IN THE STROKE UNIT SETTING 336
Narrative discourse in logopenic variant of PPA: a multi-level approach 281
Semantic memory in Object Use 279
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 255
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 238
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 206
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 200
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 196
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 196
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 192
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 189
AN ATTEMPT TO LOOK FOR DIFFERENCE BETWEEN DEGENERATIVE AND VASCULAR APHASIA: A DATA-DRIVEN CLUSTER ANALYSIS. 185
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 183
Primary progressive aphasia: linguistic patterns and clinical variants 182
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 181
POST-STROKE QUALITY OF LIFE AND COGNITIVE FUNCTIONING: A LONGITUDINAL STUDY 172
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 171
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 162
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 161
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 159
Unilateral Spatial Neglect in Degenerative Brain Pathology 147
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 145
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 140
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 139
Cognitive reserve and neuropsychological functioning in older HIV-infected people 139
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 136
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 135
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 135
Effect of aging and human immunodeficiency virus infection on cognitive abilities 133
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 131
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 130
The facial emotion recognition deficit in Parkinson's disease: Implications of a visual scanning strategy 130
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 129
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 129
Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis 125
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 124
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 121
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 121
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 118
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 115
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 114
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 109
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 106
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 106
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 102
Degenerative and Vascular Fluent Aphasia: Looking for Differences 101
Writing errors in primary progressive aphasia 99
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 98
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 95
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 90
Liver fibrosis is associated with cognitive impairment in people living with HIV 86
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 85
Cognitive reserve: a multidimensional protective factor in Parkinson's disease related cognitive impairment 82
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 74
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 73
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 71
HIV 70
Writing errors in primary progressive aphasia 67
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 59
Totale 9.249
Categoria #
all - tutte 32.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 28 56 14 59 53 72 19
2021/2022679 51 40 21 90 32 30 30 111 23 51 67 133
2022/20231.439 167 205 77 213 90 153 77 136 179 37 74 31
2023/2024939 43 172 38 60 59 194 64 52 41 46 96 74
2024/20251.552 28 53 195 78 161 57 106 80 212 120 256 206
2025/20261.638 442 62 154 336 557 87 0 0 0 0 0 0
Totale 9.249